Select a State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

New York

Before the New York State Legislature recently adjourned, both Houses passed legislation (A3040B-S4807B) which would authorize pharmacists to administer long-acting injectable medication for MH/SUD per a prescription or order. In addition, the legislature rejected efforts to delay or repeal the planned FFS (Fee for Service) transition of the pharmacy benefit set to take effect on April 1, 2023. 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-06-10T10:24:45-04:00June 10, 2022|New York|

New York

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-04-22T09:17:58-04:00April 22, 2022|New York|

New York

The State Education Department regulation expanding the pharmacist immunization authority which took effect on January 31, 2022, is set to expire on April 10. At the last Board of Regents meeting, the Board took emergency action effective April 11 to keep the regulation in effect until it can be permanently adopted at the Board May Meeting.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-04-08T12:12:02-04:00April 8, 2022|New York|

New York

The New York State COVID-19 Vaccine Team has recently updated its Guidance for the NYS COVID-19 Vaccination Program for individuals 12 years of age and older. The updates reflect the recent CDC changes in COVID-19 vaccine clinical guidance. The updates include: 

  • Options for extended intervals between doses of the mRNA primary series (pages 1 and 2)  
  • Additional details on myocarditis (page 2)  
  • J&J extended shelf life (page 11)  

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-04-01T12:34:06-04:00April 1, 2022|New York|

New York

The New York State Department of Health (NYS DOH) announced the Centers for Medicare & Medicaid Services (CMS) approval of New York’s section 1115(a) demonstration waiver. This approval is effective from April 1, 2022 through March 31, 2027. In accordance with federal guidelines, the State has 30 days to accept the related Standard Terms and Conditions (STCs), which is an operating agreement between the State and CMS.

The NYSDOH 1115(a) waiver request included a white paper  which structured the waiver request proposal around four subsidiary goals:

  1. Building a more resilient, flexible and integrated delivery system that reduces racial disparities, promotes health equity, and supports the delivery of social care;
  2. Developing supportive housing and alternatives to institutions for the long-term care population.
  3. Redesigning and strengthening health and behavioral health system capabilities to provide optimal response to future pandemics and natural disasters; and
  4. Creating statewide digital health and telehealth infrastructure

The CMS approval letter can be found on the NYS DOH website here.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-03-25T16:05:21-04:00March 25, 2022|New York|

New York

2022-03-11T10:23:51-05:00March 11, 2022|New York|

New York

2022-02-25T11:37:07-05:00February 25, 2022|New York|

New York

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-02-04T11:19:32-05:00February 4, 2022|New York|
Go to Top